NIHR: UK-LMIC Research Partnership for the UK Public Health Rapid Support Team
(https://www.nihr.ac.uk/funding/uk-lmic-research-partnership-uk-public-health-rapid-support-team-uk-phrst/2025355)

The National Institute for Health and Care Research (NIHR) has a new funding opportunity to contract a high-quality research partnership to collaborate with the UK Health Security Agency (UKHSA) to deliver the UK Public Health Rapid Support Team (UK-PHRST). The UK-PHRST works to address the threat posed by infectious disease outbreaks in low- and middle-income countries (LMICs) through an integrated triple remit incorporating:

· Outbreak response: deploying specialist public health experts to rapidly investigate and respond to disease outbreaks at source in LMICs, to stop a public health threat from becoming a broader health emergency.

· Research: delivering rigorous, collaborative research to improve the evidence base for best practice in outbreak response in LMICs.

· Capacity strengthening: strengthening leadership, systems and capacity for improved outbreak response in LMICs.

The UK-LMIC Research Partnership will deliver an ambitious, interdisciplinary programme of research aimed at improving public health responses to infectious disease outbreaks in LMICs.

Award details

a single award of up to £18 million (£3.6 million per year) for five years

Eligibility

Established researchers with the skills, knowledge, and resources necessary to carry out the proposed research as the Principal Investigator:

· must be led by a lead applicant from a research active higher education institution (HEI) based in the UK

· must include at least one co-applicant from a research active HEI or research institute in an ODA-eligible country. Preference will be given to applications which include multiple co-applicants from multiple LMIC-based institutions across different countries and/or regions.

· can include co-applicant(s) from up to two additional UK-based research active institutions.

Funder information webinar for Applicants on the 11th September 2025 -  Registration Link

Download the PDF outlining UCT’s deadlines for internal approval

Funder deadline:

27 November 2025

The Wellcome Early-Career Awards scheme is soliciting applications from early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they should deliver shifts in understanding that could improve human life, health, and wellbeing. By the end of the award, successful candidates should be equipped to lead their own independent research programme.  

 
Award details   
PI salary for up to five years and up to £400 000 for research purposes.  

Eligibility   
Early-Career Researchers.  
 
Download the PDF outlining UCT’s deadlines for internal approval.     
 
Funder deadline:   
Three deadlines annually, with the next one for 2026 being 17 February. 

https://professional.dkms.org/research-publications/research-grant

DKMS Stiftung Leben Spenden is inviting young outstanding scientists to apply for the DKMS John Hansen Research Grant 2026. Proposals must address issues on hematopoietic stem cell transplantation or cell therapy for haematological diseases. Various aspects can be covered, including but not limited to diagnostic and therapeutic strategies, transplant immunology, stem cell transplantation complications, donor selection, or cell manufacturing.

Award details  

Up to a maximum of €240,000, over a period of three years

Eligibility  

• Doctoral degree (PhD, MD, or equivalent achievements) in a field pertinent to the grant within the last 10 years from the grant call start date
• Researchers with the skills, knowledge, and resources necessary to carry out the proposed research as the Principal Investigator

Download the PDF outlining UCT’s deadlines for internal approval    

Funder deadline:  

20 November 2025 

(https://www.pfizer.com/about/programs-policies/grants/competitive-grants)  

 Pfizer and the CanAge are collaborating to offer a new grant opportunity seeking grant proposals for programs that seek to explore innovative approaches to persistent challenges impacting older adults living with rare diseases. Grants will be awarded in support of organizations/institutions working to improve programs and policies focused on improving the care of adults living with rare disease.

Refer to complete details in the full RFP document.  

Eligibility  

Researchers with the skills, knowledge, and resources necessary to carry out the proposed research as the Principal Investigator  

Award details     

• The total available budget related to this RFP is $100,000  
• Individual projects requesting up to $25,000 will be considered.

Download the PDF outlining UCT’s deadlines for internal approval    

Funder deadline:  

24 November 2025 

(https://www.samrc.ac.za/funding/request-applications-accelerating-innovation-vaginal-formulations-support-womens-health)  

The South African Medical Research Council (SAMRC), in partnership with the Bill & Melinda Gates Foundation and Grand Challenges is pleased to announce the launch of the Grand Challenges South Africa program. This Grand Challenge on Accelerating Innovation in Vaginal Formulations in Support of Women's Health is soliciting applications that contribute to development of vaginal formulations that promote optimal drug delivery within the vaginal compartment while positively supporting the vaginal milieu, and that also possess beneficial effects, even if unrelated to the API intended effect, that a user might consider desirable, such as enhancement of sexual pleasure.  

Eligibility  

• Researchers with the skills, knowledge, and resources necessary to carry out the proposed research as the Principal Investigator  
• Projects must be based in South Africa and led by South African principal investigators, who are citizens or permanent residents.
• Preference is given to projects led by women researchers and/or institutions based in LMICs and/or involving collaborations with LMIC-based organisations

Award details     

Up to US $250,000 per project, for a maximum duration of up to 2 years.

Funder webinar for Applicants on the 20th November 2025- Registration Link  

Download the PDF outlining UCT’s deadlines for internal approval    

Funder deadline:  

16 December 2025 

(https://gcgh.grandchallenges.org/challenge/accelerating-development-innovative-exceptionally-low-cost-maternal-and-child-nutrient)  

 The Grand Challenges family of initiatives fosters innovation to solve key health and development problems. This Grand Challenge on Accelerating Development of Innovative, Exceptionally Low-Cost Maternal and Child Nutrient Ingredients and Products seeks transformative innovations to drastically lower the cost of key maternal and child nutrient ingredients and supplements. The goal is to make essential nutrients—particularly calcium, choline, and omega-3 DHA—more affordable, scalable, and accessible in low- and middle-income countries (LMICs).

Award details     

2000 000 – 500 000USD, depending on the item developed, and the duration of the project

Eligibility  

Researchers with the skills, knowledge, and resources necessary to carry out the proposed research as the Principal Investigator  

Funder webinar for Applicants on the 12th November 2025- Registration Link  

Download the PDF outlining UCT’s deadlines for internal approval    

Funder deadline:  

16 December 2025